According to a study conducted in a heterogeneous group of patients with RRMS and secondary progressive MS (SPMS), a form of MS that transition from relapsing–remitting to a steadily progressive course, the rs2069727 T/C variation in the IFNG gene is associated with MS risk, a relationship observed only in male MS patients. This evidence concerns the gene IFNG and myeloid sarcoma.